Reconstruction of an Integrated Genome-Scale Co-Expression Network Reveals Key Modules Involved in Lung Adenocarcinoma

作者: Gholamreza Bidkhori , Zahra Narimani , Saman Hosseini Ashtiani , Ali Moeini , Abbas Nowzari-Dalini

DOI: 10.1371/JOURNAL.PONE.0067552

关键词:

摘要: Our goal of this study was to reconstruct a “genome-scale co-expression network” and find important modules in lung adenocarcinoma so that we could identify the genes involved adenocarcinoma. We integrated gene mutation, GWAS, CGH, array-CGH SNP array data order loci genome-scale. Afterwards, on basis identified network reconstructed from data. The named network”. As next step, 23 key were disclosed through clustering. In number have been for first time be implicated by analyzing modules. EGFR, PIK3CA, TAF15, XIAP, VAPB, Appl1, Rab5a, ARF4, CLPTM1L, SP4, ZNF124, LPP, FOXP1, SOX18, MSX2, NFE2L2, SMARCC1, TRA2B, CBX3, PRPF6, ATP6V1C1, MYBBP1A, MACF1, GRM2, TBXA2R, PRKAR2A, PTK2, PGF MYO10 are among belong 1 22. All these genes, being at least one phenomena, namely cell survival, proliferation metastasis, an over-expression pattern similar EGFR. few modules, such as CCNA2 (Cyclin A2), CCNB2 B2), CDK1, CDK5, CDC27, CDCA5, CDCA8, ASPM, BUB1, KIF15, KIF2C, NEK2, NUSAP1, PRC1, SMC4, SYCE2, TFDP1, CDC42 ARHGEF9 present play crucial role cycle progression. addition mentioned there some other (i.e. DLGAP5, BIRC5, PSMD2, Src, TTK, SENP2, DOK2, FUS etc.)

参考文章(104)
John D. Minna, Adi Gazdar, Joyce E. Ohm, Denise Juroske, Jonathan R. Pollack, Michael Peyton, Kiyoshi Yanagisawa, Yuhui Huang, Joseph Amann, J. Stuart Salmon, Hisayuki Shigematsu, David P. Carbone, Pierre P. Massion, Shailaja Kalyankrishna, Young H. Kim, Jonathan M. Kurie, Luc Girard, Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer Cancer Research. ,vol. 65, pp. 226- 235 ,(2005)
Xiaolan Zhu, Yuefeng Li, Huiling Shen, Hao Li, Lulu Long, Lulu Hui, Wenlin Xu, miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6 FEBS Letters. ,vol. 587, pp. 73- 81 ,(2013) , 10.1016/J.FEBSLET.2012.11.004
Z. Ju, M. Kapoor, K. Newton, K. Cheon, A. Ramaswamy, R. Lotan, L. C. Strong, J. S. Koo, Global detection of molecular changes reveals concurrent alteration of several biological pathways in nonsmall cell lung cancer cells Molecular Genetics and Genomics. ,vol. 274, pp. 141- 154 ,(2005) , 10.1007/S00438-005-0014-7
Gholamreza Bidkhori, Ali Moeini, Ali Masoudi-Nejad, Modeling of Tumor Progression in NSCLC and Intrinsic Resistance to TKI in Loss of PTEN Expression PLoS ONE. ,vol. 7, pp. e48004- ,(2012) , 10.1371/JOURNAL.PONE.0048004
Milind M. Pore, T. Jeroen N. Hiltermann, Frank A.E. Kruyt, Targeting apoptosis pathways in lung cancer. Cancer Letters. ,vol. 332, pp. 359- 368 ,(2013) , 10.1016/J.CANLET.2010.09.012
Boris Gabriel, Axel Zur Hausen, Jiri Bouda, Ludmila Boudova, Miroslava Koprivova, Marc Hirschfeld, Markus Jäger, Elmar Stickeler, Significance of nuclear hTra2-beta1 expression in cervical cancer Acta Obstetricia et Gynecologica Scandinavica. ,vol. 88, pp. 216- 221 ,(2009) , 10.1080/00016340802503021
Tzu-Pin Lu, Liang-Chuan Lai, Mong-Hsun Tsai, Pei-Chun Chen, Chung-Ping Hsu, Jang-Ming Lee, Chuhsing Kate Hsiao, Eric Y. Chuang, Integrated analyses of copy number variations and gene expression in lung adenocarcinoma. PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0024829
Yi Hu, Yanfang Ju, Dongmei Lin, Zhikuan Wang, Yurong Huang, Sujie Zhang, Chao Wu, Shunchang Jiao, Mutation of the Nrf2 gene in non-small cell lung cancer. Molecular Biology Reports. ,vol. 39, pp. 4743- 4747 ,(2012) , 10.1007/S11033-011-1266-4
Nancy E. Hynes, Heidi A. Lane, ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Reviews Cancer. ,vol. 5, pp. 341- 354 ,(2005) , 10.1038/NRC1609